NLRC3 affects the development of psoriasis by modulating the NF-κB signaling pathway mediated inflammatory response through its interaction with TRAF6
Immunology Letters · 2025
DOI: 10.1016/j.imlet.2024.106949 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology Letters, 2025. Verfasst von Wanlu Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, Anhui, PR China. Hauptthemen laut MEDLINE: Psoriasis, Signal Transduction, NF-kappa B, TNF Receptor-Associated Factor 6. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, Anhui, PR China.
- Department of Dermatology, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, Anhui, PR China. Electronic address: bbykdxpfk@163.com.
Zitieren
APA
Zhang, W., Zhu, G., Sun, H., & Jiang, C. (2025). NLRC3 affects the development of psoriasis by modulating the NF-κB signaling pathway mediated inflammatory response through its interaction with TRAF6. Immunology Letters. https://doi.org/10.1016/j.imlet.2024.106949
Vancouver
Zhang W, Zhu G, Sun H, Jiang C. NLRC3 affects the development of psoriasis by modulating the NF-κB signaling pathway mediated inflammatory response through its interaction with TRAF6. Immunology Letters. 2025. doi:10.1016/j.imlet.2024.106949
BibTeX
@article{Zhang2025,
author = {Zhang, Wanlu and Zhu, Gege and Sun, Huiya and Jiang, Congjun},
title = {NLRC3 affects the development of psoriasis by modulating the NF-κB signaling pathway mediated inflammatory response through its interaction with TRAF6},
journal = {Immunology Letters},
year = {2025},
doi = {10.1016/j.imlet.2024.106949}
}
EUVIMED